✦ LIBER ✦

Oral anticoagulant treatment and risk for bone fractures in uremic hemodialysed patients

✍ Scribed by I. Griveas; A. Gompou; E. Kyritsis; I. Agroyannis; M. Tsakoniatis; B. Agroyannis

Publisher: Wiley (John Wiley & Sons)
Year: 2010
Tongue: English
Weight: 55 KB
Volume: 39
Category: Article
ISSN: 0090-2934
DOI: 10.1002/dat.20427

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral mucositis in patients undergoing ra

Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma : Risk factors and clinical consequences

✍ Montserrat Vera-Llonch; Gerry Oster; May Hagiwara; Stephen Sonis 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

Prevalence of and risk factors for low b

Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus

✍ Irene E. M. Bultink; Willem F. Lems; Piet J. Kostense; Ben A. C. Dijkmans; Alexa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## Abstract ## Objective To examine the prevalence of and risk factors for low bone mineral density (BMD) and vertebral fractures in patients with systemic lupus erythematosus (SLE). ## Methods We studied 107 SLE patients. Demographic and clinical data were collected, and radiographs of the thor

Oral bisphosphonates and risk of subtroc

Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort

✍ Seo Young Kim; Sebastian Schneeweiss; Jeffrey N Katz; Raisa Levin; Daniel H Solo 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 214 KB

Bisphosphonates are the primary therapy for postmenopausal and glucocorticoid-induced osteoporosis. Case series suggest a potential link between prolonged use of bisphosphonates and low-energy fracture of subtrochanteric or diaphyseal femur as a consequence of oversuppression of bone resorption. Usi

Effect of denosumab treatment on the ris

Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis

✍ Michael R McClung; Steven Boonen; Ove Törring; Christian Roux; René Rizzoli; Hen 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 103 KB 👁 1 views

## Abstract Denosumab reduces the risk of new vertebral and nonvertebral fractures. Previous trials suggest that the efficacy of antiresorptives on fractures might differ by patients' characteristics, such as age, bone mineral density (BMD), and fracture history. In the FREEDOM study, 7808 women ag

Risk of new vertebral fractures in patie

Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: A multicenter longitudinal study

✍ Valentina Morelli; Cristina Eller-Vainicher; Antonio Stefano Salcuni; Francesca 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 89 KB

## Abstract In patients with adrenal incidentalomas (AIs), cross‐sectional studies suggested the presence of an association between subclinical hypercortisolism (SH) and an increased prevalence of vertebral fractures (VFx) and spinal deformity index (SDI), which is a clinical index of bone quality.